Wilson Asset Management International PTY Ltd. lessened its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 25.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,101 shares of the financial services provider's stock after selling 19,277 shares during the period. CME Group makes up about 4.0% of Wilson Asset Management International PTY Ltd.'s holdings, making the stock its 10th biggest holding. Wilson Asset Management International PTY Ltd.'s holdings in CME Group were worth $15,148,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of CME. Bank Pictet & Cie Europe AG lifted its holdings in shares of CME Group by 29.0% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock worth $20,190,000 after acquiring an additional 19,533 shares during the last quarter. Fisher Asset Management LLC bought a new stake in shares of CME Group in the 4th quarter worth approximately $243,000. Smartleaf Asset Management LLC lifted its holdings in shares of CME Group by 21.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 3,904 shares of the financial services provider's stock worth $904,000 after acquiring an additional 685 shares during the last quarter. Bailard Inc. lifted its holdings in shares of CME Group by 13.9% in the 4th quarter. Bailard Inc. now owns 3,990 shares of the financial services provider's stock worth $927,000 after acquiring an additional 488 shares during the last quarter. Finally, SRS Capital Advisors Inc. lifted its holdings in shares of CME Group by 7,056.5% in the 4th quarter. SRS Capital Advisors Inc. now owns 1,646 shares of the financial services provider's stock worth $382,000 after acquiring an additional 1,623 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
Insider Activity at CME Group
In related news, insider Derek Sammann sold 4,650 shares of the business's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider owned 8,336 shares in the company, valued at $2,339,164.96. The trade was a 35.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total transaction of $817,680.00. Following the completion of the sale, the director directly owned 5,400 shares in the company, valued at $1,471,824. This represents a 35.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,400 shares of company stock valued at $3,680,610 over the last three months. Corporate insiders own 0.30% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on CME. Bank of America boosted their price objective on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. UBS Group boosted their price objective on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a report on Friday, April 25th. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Piper Sandler boosted their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Finally, Morgan Stanley upped their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $259.87.
View Our Latest Report on CME
CME Group Trading Down 0.2%
Shares of NASDAQ:CME traded down $0.62 on Thursday, hitting $275.20. The company had a trading volume of 598,869 shares, compared to its average volume of 2,192,358. The firm's 50-day simple moving average is $276.00 and its two-hundred day simple moving average is $257.35. The firm has a market capitalization of $99.17 billion, a price-to-earnings ratio of 27.66, a P/E/G ratio of 3.74 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1 year low of $193.17 and a 1 year high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the previous year, the company earned $2.50 earnings per share. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. Equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
